← Leaderboards
Pablo J Prado
Livivos Inc.
$778,593
Attributed
$1,557,185
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $947.4K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,557,185 · 3
By mechanism
R44$947,354 · 1
R43$609,831 · 2
Top collaborators
- Claude B Sirlin3 shared
Others in their field
Other Rising Stars on “Fatty Liver”
- Debanjan Dhar · University Of California, San Diego$3,366,301
- Robert Nathaniel Helsley · University Of Kentucky$3,150,462
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
- Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation$3,065,252
- Pei-Hsun Wu · Johns Hopkins University$2,847,704
- Rebecca Florsheim · New York University School Of Medicine$2,726,769
Research focus
Fatty LiverHealth Services AccessibilityEpidemiology StudyFatty Acid Glycerol EstersFutureEarly DiagnosisDevicesEnrollmentDensityExtrahepaticDiagnosticEarly InterventionDrug DiscoveryCaringCostClinically SignificantCommunitiesClinical TrialsBiological MarkersClinicClinical ApplicationAgreementDiagnosisHepatic
Grant awards (3)
Accurate Point of Care Liver Disease Diagnostics, Phase II$947,354
R44 · FY2025 · DK · contact PI
Point-of Care MR Device to Estimate T1 Relaxation Time as a Biomarker of Liver Disease (resubmission)$309,974
R43 · FY2023 · EB · contact PI
Accurate Point of Care Liver Disease Diagnostics$299,857
R43 · FY2022 · DK · contact PI